Lecture Details - Table of Contents

Eighth International Congress on Genitourinary Malignancies

Jul 17-19, 2008, Washington, DC

Release Date: July 31, 2008

Table of Contents

State-of-the-Art Management of Bladder Cancer
Moderator: Derek Raghavan

Advances in the Treatment of Bladder Cancer
Derek Raghavan

Surgical Issues and Treatment of Non-Muscle-Invasive Bladder Cancer
Seth Lerner

Current Neoadjuvant and Adjuvant Therapies for Bladder Cancer
Jonathan Rosenberg

Optimal Chemotherapy for Advanced Disease
Guru Sonpavde

Non–Clear Cell Renal Cell Carcinoma
Moderator: Toni Choueiri

Papillary Renal Cell Carcinoma
Toni Choueiri

Chromophobe Renal Cell Carcinoma/Collecting Duct Carcinoma
Janice Dutcher

Debate: Controversies in the Treatment of Small Renal Tumors
Moderator: Steven C. Campbell

Surgery for Small Renal Tumors
Andrew Novick

No Surgery for Small Renal Tumors
Robert Uzzo

Advances in the Treatment of Advanced/Metastatic Renal Cell Carcinoma: Treatment-Naive Patients
Moderator: Robert Motzer

Management of Locally Advanced Renal Cell Carcinoma
Steven C. Campbell

What Is the Standard of Care for Newly Diagnosed Renal Cell Carcinoma?
David I. Quinn

Use of Targeted Agents in Advanced Renal Cell Carcinoma: Combine or Sequence?
Robert Motzer

Advances in the Treatment of Metastatic Renal Cell Carcinoma: Refractory Patients
Moderator: Thomas Hutson

Optimal Treatment Choices for the Refractory Patient: Case-Based Panel Discussion on Sequencing, Dose, and Treatment Failures
Thomas Hutson

Molecular Biology and Clinical Practice in Genitourinary Malignancies
Moderator: Ronald Bukowski

Biomarkers in Renal Cell Carcinoma
Ronald Bukowski

Defining Poor-Prognosis Patients With Advanced Renal Cell Carcinoma
Gary Hudes

Risk Alleles in Prostate Cancer
Matthew Freedman

Progress in Prostate Cancer Research
Edward Gelmann

Immunologic Approaches to Genitourinary Malignancies
Moderator: David McDermott

Kidney Cancer
David McDermott

Prostate Cancer
Susan Slovin

Novel Agents in Genitourinary Malignancies
Moderator: Oliver Sartor

Bladder Cancer
Derek Raghavan

Renal Cell Carcinoma
David McDermott

Prostate Cancer
Oliver Sartor

State-of-the-Art Management of Prostate Cancer
Moderator: Eric Klein

Preventing Prostate Cancer: Update 2008
Eric Klein

Prostate Cancer Surgery: What’s New?
James Eastham

Radiation Therapy: Current and Future Concepts
Howard Sandler

Chemotherapy Trials in Prostate Cancer: Overview and Update
Daniel P. Petrylak

Debate: Active Surveillance vs. Intervention Treatment Strategies for Early-Stage Prostate Cancer
Moderator: Matthew Smith

Do We Overtreat Prostate Cancer?
Laurence Klotz

Focal Therapy: Has Its Time Arrived?
E. David Crawford

Issues in Bone Health
Moderator: Oliver Sartor

Osteoporosis and Skeletal-Related Events: Whats New?
Matthew Smith

Radiopharmaceutical Update
Oliver Sartor

Localized Prostate Cancer: Treating the Spectrum of Disease
Moderator: Howard Sandler

Hormones and Radiation: When and How Much?
Mack Roach III

Dose Escalation: When Does It Matter?
Howard Sandler

Salvage Radical Prostatectomy
Graeme Steele

Adjuvant or Salvage Radiation Therapy: Current Data and Future Plans
Alan Pollack

Instructions for Participation

To view the streaming Flash Video lectures, click the "View Flash Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>

To download Podcast-ready movies, click "Download Video Podcast," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>

Please scroll to the bottom and accept the Activity Terms in order to continue:

Disclaimer

Physicians’ Education Resource presents this resource for educational purposes only. Participants are expected to use their own expertise and judgment while engaged in the practice of medicine. Please consult full prescribing information for any drugs or procedures discussed within.

The views and opinions expressed in these presentations are those of the authors and do not necessarily reflect the views of the sponsor, supporter, or publisher. Although great care has been taken in compiling and checking the information given in this publication to ensure accuracy, the authors and Physicians’ Education Resource and its servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions, or inaccuracies in this publication, whether arising from negligence or otherwise howsoever or for any consequences arising therefrom.

Disclosure of Unlabeled Uses

This reference may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physician’s Desk Reference.

All rights reserved; for personal use only. No part of this presentation may be translated, reproduced or transmitted by any means or in any type of media form including electronic, mechanical photocopying, recording, broadcasting, or otherwise without prior permission from the publisher.

Software Requirements

The Web pages and Web-based applications require a minimum Web browser of Microsoft Internet Explorer 5.5 or higher, Mozilla Firefox 1.0 or higher, or another compatible Web browser.

If you are not sure of the version of your browser, select Help in the menu bar of your browser, then select About.

PC Users
If you need to upgrade your Web browser, follow one of the links listed below:

Macintosh Users
Compatible Web browsers include

Educational Grants

An educational grant for this activity was provided by:


  1. Novartis Oncology
  2. Merck Oncology
  3. sanofi-aventis U.S.
  4. Wyeth Pharmaceuticals
  5. Bayer HealthCare Pharmaceuticals/
    Onyx Pharmaceuticals, Inc.
  6. Genentech BioOncology
  7. Bristol-Myers Squibb